infliximab
Showing 1 - 25 of 168
IBD, Crohn Disease, Ulcerative Colitis Trial (Infliximab)
Not yet recruiting
- Inflammatory Bowel Diseases
- +2 more
- Infliximab
- (no location specified)
Oct 27, 2023
Therapeutic Monitoring of Infliximab and Adalimumab
Recruiting
- Inflammatory Bowel Diseases
- Infliximab
- Adalimumab
-
Trieste, ItalyIRCCS Burlo Garofolo
Sep 5, 2023
Crohn Disease Trial in Beijing (Infliximab)
Not yet recruiting
- Crohn Disease
- Infliximab
-
Beijing, ChinaBeijing Children's Hospital, Capital Medical University
Jun 13, 2023
Crohn Disease, Infliximab Trial (Azathioprine, Infliximab)
Not yet recruiting
- Crohn Disease
- Infliximab
- Azathioprine
- Infliximab
- (no location specified)
Apr 3, 2023
Depressive Disorder, Major, Inflammation Trial (Infliximab, Placebo)
Not yet recruiting
- Depressive Disorder, Major
- Inflammation
- Infliximab
- Placebo
- (no location specified)
Nov 21, 2023
Colitis Trial in Aalborg, Odense, London (Infliximab, Methylprednisolone, Prednisolone)
Not yet recruiting
- Colitis
- Infliximab
- +2 more
-
Aalborg, Denmark
- +2 more
Jul 7, 2023
Crohn Disease, Child, Only, Biologic; Inadequate Trial (Infliximab)
Not yet recruiting
- Crohn Disease
- +2 more
- Infliximab
- (no location specified)
Sep 20, 2022
Infliximab in the Treatment of Chinese Crohn's Disease
Active, not recruiting
- Crohn Disease
- Infliximab
-
Guangzhou, China
- +4 more
Jan 31, 2023
IBD Trial in Saint Louis (Infliximab)
Active, not recruiting
- Inflammatory Bowel Diseases
- Infliximab
-
Saint Louis, MissouriWashington University School of Medicine
Aug 31, 2022
Idiopathic Refractory Scleritis Trial (Infliximab, Cyclophosphamide)
Withdrawn
- Idiopathic Refractory Scleritis
- Infliximab
- Cyclophosphamide
- (no location specified)
Jul 18, 2022
COVID-19 Trial in Jena (Infliximab, Standard of Care)
Recruiting
- COVID-19
- Infliximab
- Standard of Care
-
Jena, GermanyJena University Hospital
Aug 10, 2022
Ulcerative Colitis Trial in Melbourne (Infliximab)
Active, not recruiting
- Ulcerative Colitis
- Infliximab
-
Melbourne, Victoria, AustraliaAustin Health
Jun 19, 2022
A Cohort Study Comparing IFX to CS for Moderate to Severe UC
Recruiting
- Moderate to Severe Ulcerative Colitis
- Infliximab
- Corticosteroid
-
Guandong, ChinaThe Sixth Affiliated Hospital, Sun Yat-sen University
Nov 22, 2022
Tocilizumab Versus Tocilizumab/Infliximab in COVID-19-associated
Completed
- Covid19
- +2 more
- Tocilizumab
- Infliximab
-
Cairo, Please Select, EgyptTeachers Hospital
Jul 19, 2022
Crohn Disease Trial in United States (RoadMAB, Infliximab)
Not yet recruiting
- Crohn Disease
- RoadMAB
- Infliximab
-
Los Angeles, California
- +9 more
Dec 19, 2022
Aneurysm, Stroke, Vasculitis Trial in San Francisco (Infliximab)
Enrolling by invitation
- Aneurysm
- +3 more
- Infliximab
-
San Francisco, CaliforniaUCSF Medical Center
Apr 25, 2022
Biomarkers to Predict and Monitor Response to Infliximab
Recruiting
- Crohn Disease
- Infliximab
-
Boston, MassachusettsMassGeneral for Children
Apr 5, 2022
IBD Trial in Leuven (Infliximab)
Recruiting
- Inflammatory Bowel Diseases
- Infliximab
-
Leuven, Vlaanderen, BelgiumUZ Leuven
Feb 11, 2022
Metastatic Melanoma Trial in Boston (Pembrolizumab, Infliximab, Placebo)
Recruiting
- Metastatic Melanoma
- Pembrolizumab
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Apr 6, 2022
Depression Trial in Atlanta (Infliximab, Placebo)
Active, not recruiting
- Depression
- Infliximab
- Placebo
-
Atlanta, GeorgiaEmory University
Jan 23, 2023
Schizophrenia Trial in Atlanta (Infliximab, Placebo)
Not yet recruiting
- Schizophrenia
- Infliximab
- Placebo
-
Atlanta, Georgia
- +1 more
Apr 10, 2023
Irritable Bowel Disease Trial in Cairo (Infliximab, Adalimumab)
Recruiting
- Irritable Bowel Disease
- Infliximab
- Adalimumab
-
Cairo, EgyptTropical Medicine department, Ain Shams University Hospitals.
Mar 12, 2022
Fate in Fistulizing Crohn's Disease in a Pediatric Population
Active, not recruiting
- Crohn Disease
- Infliximab
- Stomy
- (no location specified)
Feb 25, 2023
IBD Trial in Trieste (Infliximab)
Recruiting
- Inflammatory Bowel Diseases
- Infliximab
-
Trieste, ItalyInstitute for Maternal and Child Health - IRCCS "Burlo Garofolo"
Mar 18, 2022
Colitis, Ulcerative Trial in Amsterdam (Infliximab)
Recruiting
- Colitis, Ulcerative
- Infliximab
-
Dublin, Ireland
- +6 more
Dec 2, 2022